Development of a Robust Flow Cytometry-Based Pharmacodynamic Assay to Detect Phospho-Protein Signals for Phosphatidylinositol 3-Kinase Inhibitors in Multiple Myeloma

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-11-76
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2013English

Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Phosphatidylinositol 3-Kinase Mediates Proliferative Signals in Intestinal Epithelial Cells

Gastroenterology
HepatologyGastroenterology
2003English

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2013English

Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase Α Inhibitors

ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY
2019English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Development of New Molecular Markers for Cancer: A Highly Sensitive Assay for Detecting Mutations of Phosphatidylinositol 3-Kinase and P53

Journal of Nippon Medical School
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy